Get started
Brii Biosciences LimitedBrii Biosciences LimitedBrii Biosciences Limited

Brii Biosciences Limited

No trades
See on Supercharts
OverviewFinancialsNewsIdeasMindsForecastsSeasonals

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪148.86 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.060 EUR
Net income (FY)
‪−68.49 M‬ EUR
Revenue (FY)
0.00 EUR
Shares float
‪650.35 M‬
Beta (1Y)
1.24

Employees


Employees (FY)
98
Change (1Y)
−30 −23.44%
Revenue / Employee (1Y)
—
Net income / Employee (1Y)
—

About Brii Biosciences Limited


Sector
Health Technology
Industry
Biotechnology
CEO
Zhi Hong
Website
briibio.com
Headquarters
Haidian
Founded
2017
ISIN
KYG1645A1094
FIGI
BBG011VMBX99
Brii Biosciences Ltd. engages in advancing therapies for significant infectious diseases and other illnesses which have significant public health burdens. The firm also focuses on developing therapies for infectious diseases and central nervous system diseases. The company was founded by Zhi Hong on December 8, 2017, and is headquartered in Beijing, China.

Check out other big names from the same industry as 7SS.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on TRADEGATE exchange Brii Biosciences Limited stocks are traded under the ticker 7SS.
We've gathered analysts' opinions on Brii Biosciences Limited future price: according to them, 7SS price has a max estimate of 0.22 EUR and a min estimate of 0.22 EUR. Watch 7SS chart and read a more detailed Brii Biosciences Limited stock forecast: see what analysts think of Brii Biosciences Limited and suggest that you do with its stocks.
7SS reached its all-time high on Sep 29, 2021 with the price of 5.650 EUR, and its all-time low was 0.091 EUR and was reached on Dec 17, 2024. View more price dynamics on 7SS chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Brii Biosciences Limited financials in yearly and quarterly reports right on TradingView.
Brii Biosciences Limited is going to release the next earnings report on Mar 20, 2026. Keep track of upcoming events with our Earnings Calendar.
7SS earnings for the last half-year are −0.02 EUR per share, whereas the estimation was −0.03 EUR, resulting in a 25.93% surprise. The estimated earnings for the next half-year are −0.01 EUR per share. See more details about Brii Biosciences Limited earnings.
Brii Biosciences Limited revenue for the last half-year amounts to ‪3.35 M‬ EUR, matching the estimated figure, and no changes in revenue are expected for the next half-year.
7SS net income for the last half-year is ‪−17.19 M‬ EUR, while the previous report showed ‪−30.69 M‬ EUR of net income which accounts for 43.98% change. Track more Brii Biosciences Limited financial stats to get the full picture.
No, 7SS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 3, 2025, the company has 98 employees. See our rating of the largest employees — is Brii Biosciences Limited on this list?
Like other stocks, 7SS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Brii Biosciences Limited stock right from TradingView charts — choose your broker and connect to your account.